Navigation Links
Research output in developing countries reveals 194 percent increase in five years
Date:7/2/2009

ia) and one Band 2 country (Bulgaria) reveals a remarkable progression of article output from 1996 2008. By contrast, the non Research4Life country Japan (for example) showed steady and continuous growth over this period without a sharp change in output over the period analysed.

"The opportunities to conduct original scholarly research without access to the world's published literature are limited. Discoveries build on generations of research done previously," remarked Kimberly Parker, HINARI Program Manager at the WHO. "Research4Life has extended the reach of that scholarly heritage into the developing world, increasing researchers' opportunities to participate in the global research community by conducting groundbreaking research, collaborating with global colleagues, and in time contributing to evidence-based scientific policy in their own countries. We are very excited to see the growing output coming from the developing world."

Dr Andrew Plume noted, "The massive and sustained growth in scholarly output from the Research4Life countries, over and above the growth for the rest of the world, is probably the result of many related factors such as scientific policy, government and private research funding, and other global developments. However, such a dramatic increase in research output also reflects a clear correlation with the launch of the Research4Life programmes. These statistics point to Research4Life's profound impact on institutions and individual researchers' ability to publish."

"Since we have had access to Research4Life, the researchers, and especially the clinicians at the College of Medicine, University of Port Harcourt, have been able to engage more with the global science community," stated Henrietta Otokunefor, Automation Librarian at the University of Port Harcourt Library in Nigeria. "The library computers and those at the ICTC for faculty are often occupied and I've seen a growth in published research from our st
'/>"/>

Contact: Shira Tabachnikoff
s.tabachnikoff@elsevier.com
31-204-852-736
Elsevier
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Liverpool to strengthen health research in Africa
2. Grant received for eye disorder research
3. Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute
4. International Collaboration led by Dr. Pablo V. Gejman,Researcher At NorthShore University HealthSystem's Research Institute, Finds Genetic Association of Schizophrenia to Chromosome 6p Variant
5. 6th Annual Neurosurgery Charity Softball Tournament Hits It Out of the Park For Pediatric Brain Tumor Research Fund
6. Beacon Equity Researches: Sanofi-Aventis, Amazon, Yahoo, Johnson & Johnson, Novavax and NexMed
7. Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis, But Worries About Risk of Rationing
8. Damon Runyon Cancer Research Foundation awards $2.7M to 7 top young clinical investigators
9. Colorado professor recognized for outstanding published work in public health systems research
10. IU School of Optometry named national vision research center
11. Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...tal (RTDental), a leading dental group practice in...sion of its services to include LUMINEERS by a cer... Durham, NC (PRWEB) -- Res...Dr. Doug Macmillan, an experienced LUMINEERS Den...aining seminar. RTDental’s ability to fulfi...
(Date:11/25/2009)...stCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: ONXX )...ntsinDecember: ,, ASHBriefing ,, Decem...investigatorswilldiscussdatapresentationssurroundi...loma,asfeaturedatthe51stAmericanSocietyofHematolog...eteleconferencewillbeginat9:00a.m.CT/10:00a.m.ETon...
(Date:11/25/2009).../--TheBlackAIDSInstituterecentlyheldBoardofDirecto..., ThenewBoardMembersareahighlydiversegroupoflea...rnmenthealthprograms,editorial,andbusinessentrepre...backgroundsincludingbothheterosexualandgayBlackmen...ngmultipleagegroups. ,, (Photo: http://www.news...
(Date:11/25/2009)...ollaboration between UCLA engineers and physicians...lion Americans who suffer from peripheral arterial...rteries, peripheral arterial disease, or PAD, is a...ries reduce blood flow to the limbs. The condition...art attack and stroke, and its progression can res...
(Date:11/25/2009)...erlook needed care, study finds , , WEDN...ession can worsen her child,s asthma, U.S. researc... black mothers and their children found that child... more frequent asthma symptoms, while children of ...equent asthma symptoms. , The Johns Hopkins Chi...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2
..., Calif., Feb. 12 Fisher Vista, LLC, a marketing,...or care and human resource,industries today announ...pany,for seven years, has been named president of ...p. Mr. Grossman will continue,to report to Mark M...
...nzastaurin, even tumors that did develop weren,t a... 12 (HealthDay News) -- A drug called enzastaurin ...cer in mice, and tumors that did develop were less...dings, coupled with the fact that the drug appears...
...d CEO, Scott Grisanti, Publishes Letter Outlining ...am , , BETHEL, Conn., Feb. 12 MedClean Technolog...f innovative technology and services for the onsit...s. The letter, which is available on the Company,...
...eb. 12 After Phil Cohen, president of Cleveland-b...nterview last year, he signed on to do three more ... introduced those videos this week via PRN Funding... three featured factoring educational videos are a...
...pels Myths Surrounding Essential Fat , , ST. LOUI...an Heart Association (AHA) concludes that omega-6 ...en part of a healthy eating plan. Omega-6s are ess...on leading to heart disease, the nation,s number o...
... to discuss fourth quarter financial results - , ...pharm Inc. (TSX: DDS; NASDAQ: DDSS ) today annou...ay, February 26 at 8:30 a.m. (ET) to discuss its f...same day. , To access the conference call by telep...
Other Medicine News:Health News:Kevin Grossman Named President of HRmarketer.com 2Health News:Drug Inhibits Colon Cancer in Mice 2Health News:MedClean Technologies Inc. CEO Publishes Letter to Shareholders 2Health News:PRN Funding Introduces the PRN Funding YouTube Channel 2Health News:American Heart Association Finds Omega-6 Fatty Acids in Soybean Oil Are Heart-Healthy 2Health News:American Heart Association Finds Omega-6 Fatty Acids in Soybean Oil Are Heart-Healthy 3Health News:Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET) 2
(Date:11/25/2009)...Nov.25/PRNewswire/--CempraPharmaceuticalsInc.today...fexecutiveofficer,willpresentatthePiperJaffray21st...2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Ferna...ntibioticclinicalprogramsforthetreatmentofdrug-res...armaceuticals ,, Foundedin2006,CempraPharmaceu...
(Date:11/25/2009)...if.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announ...sPROTECT-1(theProspectiveRandomizedOralTherapyEval...82-B)inpatientswithmoderate-to-severeCrohn,sdiseas...ndtolerabilityprofile.Thestudydemonstratedevidence...sdefinedasa70-pointdecreaseintheCrohn,sDiseaseActi...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRML)...fReorganizationandDisclosureStatementtoday,Novembe...istrictofDelaware.AhearingtoconsiderapprovaloftheD...,2009,withthehearingontheconfirmationofthePlansche...panytopayallclaimsinfull.ThePlanisexpected,ifappro...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 1Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 2Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 3Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 4Ultimat Vodka Joins Fight Against Hunger 61545 1Ultimat Vodka Joins Fight Against Hunger 61545 2Shopko Announces Launch of e Commerce Platform 61542 1Shopko Announces Launch of e Commerce Platform 61542 2
...HAYWARD, Calif., Aug. 6 Kosan Biosciences,Incorpo... Inc. has initiated,a Phase 1 clinical trial of mo...187, a selective and potent motilin receptor agoni...hageal reflux disease (GERD) and potentially,other...ical trial is,designed to test the safety, tolerab...
...SAN DIEGO, Aug. 7 Vical Incorporated (Nasdaq:,VIC...r ended June 30, 2007.,Revenues for the second qua...nues of $7.3 million for the second quarter of 200... $8.2 million, or $0.21 per share, compared,with a... the second quarter,of 2006. The increase in net l...
Other Medicine Technology:Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 2Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 3Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 2Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 3Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 5Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 6
Jeweler Type Bipolar Insulated Forceps
Robb Tonsil Knife
Canfield Tonsil Knife
Converse Button End Bistoury
Medicine Products: